Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Calls For Reporting Requirements, Recall Authority Remain As PCA Crumbles

This article was originally published in The Tan Sheet

Executive Summary

FDA would have been able to act earlier to limit the impact of contaminated peanut products if food firms were required to report all positive tests for contaminants, according to an agency executive

Related Content

FDA Stings Beehive Botanicals For Web Links That "Fell Through The Cracks"
Attention To Details Helps Firms Conduct "Short And Sharp" Recalls - Experts
Pharma Firms Stir OTC Market, FDA Hones Enforcement: Top Stories Of 2009
Acheson Sees Recent Food Problems As "Eye-Opener" For Bumpy Road Ahead
Whey Recall Grows, But Plainview Approach May Prevent A Peanut Replay
Sharfstein Defends FDA User Fees As Key To A New Food Safety System
Globalization Act’s Drug Safety Provisions Look Harmful For Industry
Nominations To Lead FDA Coming Soon For Hamburg And Sharfstein
No Small Peanuts: Obama Budget Outline Puts $1 Billion Toward Food Safety
Salmonella Problem Stirs Food Safety Bills, Hearing From Energy & Commerce





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts